• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, November 17, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Preoperative Staphylococcus Aureus Screening Evaluated in Breast Reconstruction Cohort

by
November 9, 2026
in Health
Reading Time: 3 mins read
0
Preoperative Staphylococcus Aureus Screening Evaluated in Breast Reconstruction Cohort

Preoperative Staphylococcus Aureus Screening Evaluated in Breast Reconstruction Cohort

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Preoperative nasal screening for Staphylococcus aureus was not independently associated with a statistically significant reduction in surgical site infections following implant-based breast reconstruction, according to a real-world retrospective cohort study conducted at the Veneto Institute of Oncology–IRCCS. While surgical site infections complicate implant-based reconstructive procedures and preoperative screening with targeted decolonisation is recommended in selected high-risk implant surgeries, its clinical role in breast reconstruction had remained unclear. The investigators evaluated whether introducing preoperative screening influenced infection rates across an extended twelve-month monitoring period.

The retrospective investigation encompassed 1,535 implant-based breast reconstruction procedures performed between 2020 and 2023. Starting in 2022, preoperative nasal Staphylococcus aureus screening was gradually introduced into clinical practice at the institute, serving as the primary exposure variable by comparing screened procedures with unscreened procedures. When screening identified patients as nasal carriers, targeted decolonisation protocols were prescribed; however, targeted decolonisation was not evaluated as an independent exposure in the analysis. Researchers established surgical site infection during a study-specific twelve-month follow-up window as the primary outcome, while secondary analyses examined twelve-month hospital readmissions and the relationship between nasal colonisation and subsequent clinical outcomes among screened cases using Cox proportional hazards models for time-to-event assessment.

Across the four-year study cohort, preoperative screening was carried out prior to 564 procedures, accounting for 36.7 percent of the reconstructive surgeries. Among those who underwent testing, 111 procedures, or 19.7 percent, were confirmed to have nasal Staphylococcus aureus colonisation. Over the twelve months of postoperative observation, surgical site infections occurred after 85 of the 1,535 procedures, yielding an overall incidence rate of 5.5 percent. Annual infection figures demonstrated a significant decline over the study period, dropping from 8.7 percent in 2020 to 3.5 percent in 2023 (p = 0.011). Timing analyses revealed that the vast majority of complications arose early in the postoperative trajectory, with 78 of the 85 recorded infections (91.8 percent) manifesting within ninety days of surgery. Microbiological evaluations confirmed that Staphylococcus aureus was the most frequently isolated pathogen, accounting for 29 of the 85 infections (34.1 percent).

In multivariable time-to-event analyses, preoperative screening showed an association with a lower adjusted hazard of surgical site infection, but the observed difference did not reach statistical significance (adjusted hazard ratio 0.68, 95 percent confidence interval 0.38 to 1.20; p = 0.183). Hospital readmissions were documented following 52 reconstructive procedures, representing 3.4 percent of the cohort, and were primarily driven by infectious complications. Among the subset of procedures where preoperative screening took place, positive nasal colonisation with Staphylococcus aureus was associated with a statistically significant increase in the hazard of hospital readmission within twelve months (adjusted hazard ratio 3.04, 95 percent confidence interval 1.01 to 9.11; p = 0.048).

The analysis also identified multiple patient-level and procedural factors that influenced complication rates. Older patient age was associated with an increased hazard of surgical site infection (adjusted hazard ratio 1.03; p = 0.023), as was higher body mass index (adjusted hazard ratio 1.06; p = 0.009). The administration of neoadjuvant therapy was likewise linked to an elevated infection hazard (adjusted hazard ratio 1.68; p = 0.049). Procedural choices also altered outcomes: the use of tissue expanders was associated with more than double the hazard of hospital readmission (adjusted hazard ratio 2.08; p = 0.033) and showed a borderline association with increased surgical site infection hazard (adjusted hazard ratio 1.67; p = 0.050). Conversely, procedures involving expander-to-implant exchange demonstrated a protective effect, being associated with a lower hazard of infection (adjusted hazard ratio 0.43; p = 0.030).

Based on these findings, the study authors concluded that while preoperative Staphylococcus aureus screening did not independently provide a statistically significant reduction in surgical site infections, detecting nasal carriage successfully identified a vulnerable subgroup facing a higher risk of hospital readmission. The researchers emphasized that implant-based breast reconstruction involves a non-negligible risk of infection that shifts across patient baseline characteristics and reconstructive stages, presenting greater risk during initial tissue expander placement and lower risk during exchange procedures. They suggested that screening protocols may help guide clinical risk stratification, closer postoperative monitoring, and targeted perioperative prevention efforts, while highlighting that future research must further evaluate clinical effectiveness, organisational impact, and cost-effectiveness.

Subject of Research: Preoperative Staphylococcus aureus screening in implant-based breast reconstruction

Article Title: Preoperative Staphylococcus aureus screening and surgical site infection within 12 months after implant-based breast reconstruction: a real-world retrospective cohort study

Article References: Geppini, R., Zanon, S., Cozzolino, C., Marchet, A., Mora, G., Toffanin, M., Ferrucci, M., Coppola, M., Pauletti, G., Reginato, E., Marchi, E., Gatto, A., Salmaso, D., Stefano, A., Bernardi, M., Baldovin, T., Saieva, A. M., & Ottolitri, K. (2026). Preoperative Staphylococcus aureus screening and surgical site infection within 12 months after implant-based breast reconstruction: a real-world retrospective cohort study. Antimicrobial Resistance & Infection Control. https://doi.org/10.1186/s13756-026-01829-1

Image Credits: AI Generated

DOI: 10.1186/s13756-026-01829-1

Keywords: Staphylococcus aureus, breast reconstruction, surgical site infections, preoperative screening, tissue expanders, retrospective cohort study, infection control, hospital readmission, Preoperative, Staphylococcus, aureus, screening

News Source: Ophelia Keating. (November 9, 2026). Preoperative Staphylococcus Aureus Screening Evaluated in Breast Reconstruction Cohort. Scienmag.

Tags: aureusbreast reconstructionhospital readmissionInfection controlpreoperativepreoperative screeningretrospective cohort studyscreeningStaphylococcusStaphylococcus aureussurgical site infectionstissue expanders
Share12Tweet7Share2ShareShareShare1

Related Posts

Fusobacterium nucleatum Extracellular Vesicles Trigger Neuroinflammation and Anxiety-Like Behaviors via IL-1β

Fusobacterium nucleatum Extracellular Vesicles Trigger Neuroinflammation and Anxiety-Like Behaviors via IL-1β

November 17, 2026
Immune Cell Exhaustion May Drive Neurodegeneration in Alzheimer's and Parkinson's

Immune Cell Exhaustion May Drive Neurodegeneration in Alzheimer’s and Parkinson’s

November 17, 2026

Posterior Cruciate Ligament Continuously Lengthens Across Knee Flexion in Healthy Adults

November 17, 2026

3D-Printed Guide Template Associated With Improved Spinal Deformity Correction in Cohort

November 17, 2026

POPULAR NEWS

  • Review Highlights Multi-Level Factors Influencing Clinical AI Adoption by Healthcare Providers

    Review Highlights Multi-Level Factors Influencing Clinical AI Adoption by Healthcare Providers

    29 shares
    Share 12 Tweet 7
  • Gut Microbiota and Metabolites Influence Immunotherapy Response in Liver Cancer

    29 shares
    Share 12 Tweet 7
  • Nonlinear Sex-Specific Remodeling of the TCRβ Repertoire During Adult Aging

    29 shares
    Share 12 Tweet 7
  • Capped Nanovials Enable Extended Cell Growth and Screening in UCLA Study

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Fusobacterium nucleatum Extracellular Vesicles Trigger Neuroinflammation and Anxiety-Like Behaviors via IL-1β

Experiential Workshop Expands Mexican Students’ Understanding of Bat Diets and Ecological Roles

Immune Cell Exhaustion May Drive Neurodegeneration in Alzheimer’s and Parkinson’s

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 88 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.